All dog products
All cat products
All farm animal products
All horse products
All our products
All clinical articles
Category:
Species:
Suprelorin® Now Offers an Alternative to Surgical Castration in Cats
Virbac is pleased to announce that Suprelorin® 4.7mg Implants for Dogs, the innovative reversible alternative to surgical castration is now also licensed for use in male cats.
Suprelorin®
There’s more than one way to crack a nut
Canine Castration: Is There More Than One Way To Crack A Nut?
Along with positive socialisation, training and appropriate nutrition, castration is often considered a key component of responsible dog ownership. As well as preventing accidental mating, castration can be beneficial in preventing specific testosterone related disease and can help in the management of some behavioural issues.
New Tramvetol® - Licensed Tramadol Tablets for Dogs
Virbac are pleased to announce the launch of Tramvetol®, licensed tramadol tablets for the treatment of acute and chronic pain in dogs.
New BVA Guidance Recommends Medical Option as First Choice for Essential Neutering During Covid-19
Updated guidance from the British Veterinary Association (BVA) on neutering small animals during the COVID-19 pandemic, recommends that when neutering is considered essential within the next 2 months, medical options should be first considered.
Vetflurane®
Isoflurane gaseous anaesthetic for use as a non-irritant, inhalant general surgical anaesthetic for cats, dogs and horses
Helping Your Practice Cope with the Post-Pandemic Puppy Boom
With pressure on veterinary services higher than ever and an expanding population of pets with owners desiring alternatives to surgical castration, Virbac are pleased to offer Suprelorin®.
Zoletil® 100
Tiletamine & Zolazepam from Virbac. Now with extended shelf-life.
End of content
No more pages to load
This content is disabled.
You have chosen to disable the ""Marketing"" cookies in your preferences. As a consequence, this content has therefore been disabled.
Manage Cookies
You are about to leave this site
The information displayed on the destination site is dependent on the local regulations in force.
ReturnContinue
Your profile doesn't allow you to view this content.